195 related articles for article (PubMed ID: 10562305)
1. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.
Dalod M; Dupuis M; Deschemin JC; Goujard C; Deveau C; Meyer L; Ngo N; Rouzioux C; Guillet JG; Delfraissy JF; Sinet M; Venet A
J Clin Invest; 1999 Nov; 104(10):1431-9. PubMed ID: 10562305
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
3. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
Buseyne F; Scott-Algara D; Corre B; Porrot F; Monchatre E; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
Virology; 2006 Oct; 354(2):271-9. PubMed ID: 16904156
[TBL] [Abstract][Full Text] [Related]
4. Terminally differentiated CD8 cells in HIV-infected children: HIV-GAG/POL specificity and IFN-γ production.
Delbeck D; Siepermann M; Feyen O; Wirth S; Baumann U; Wintergerst U; Oette M; Adam R; Jetzek-Zader M; Niehues T
Klin Padiatr; 2011 Jul; 223(4):214-20. PubMed ID: 21472637
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
6. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ
AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658
[TBL] [Abstract][Full Text] [Related]
7. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
[TBL] [Abstract][Full Text] [Related]
9. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
[TBL] [Abstract][Full Text] [Related]
11. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.
Makedonas G; Bruneau J; Alary M; Tsoukas CM; Lowndes CM; Lamothe F; Bernard NF
AIDS; 2005 Feb; 19(3):251-9. PubMed ID: 15718835
[TBL] [Abstract][Full Text] [Related]
12. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
Tang YB; Tang XP; Jin X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):217-9. PubMed ID: 17971925
[TBL] [Abstract][Full Text] [Related]
13. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
14. CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects.
Huang XL; Fan Z; Kalinyak C; Mellors JW; Rinaldo CR
Clin Diagn Lab Immunol; 2000 Mar; 7(2):279-87. PubMed ID: 10702505
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
Fu TM; Dubey SA; Mehrotra DV; Freed DC; Trigona WL; Adams-Muhler L; Clair JH; Evans TG; Steigbigel R; Jacobson JM; Goepfert PA; Mulligan MJ; Kalams SA; Rinaldo C; Zhu L; Cox KS; Guan L; Long R; Persaud N; Caulfield MJ; Sadoff JC; Emini EA; Thaler S; Shiver JW
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):67-76. PubMed ID: 17263635
[TBL] [Abstract][Full Text] [Related]
16. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
[TBL] [Abstract][Full Text] [Related]
17. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.
Bansal A; Gough E; Sabbaj S; Ritter D; Yusim K; Sfakianos G; Aldrovandi G; Kaslow RA; Wilson CM; Mulligan MJ; Kilby JM; Goepfert PA
AIDS; 2005 Feb; 19(3):241-50. PubMed ID: 15718834
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
Critchfield JW; Lemongello D; Walker DH; Garcia JC; Asmuth DM; Pollard RB; Shacklett BL
J Virol; 2007 Jun; 81(11):5460-71. PubMed ID: 17344302
[TBL] [Abstract][Full Text] [Related]
19. Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals.
Mendiratta S; Vajpayee M; Mojumdar K; Chauhan NK; Sreenivas V
Vaccine; 2011 Feb; 29(6):1150-8. PubMed ID: 21172377
[TBL] [Abstract][Full Text] [Related]
20. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]